Kahn RS - Search Results

1

On the value of measuring dopamine, norepinephrine and their metabolites in schizophrenia.

Kahn RS, Davidson M. Kahn RS, et al. Neuropsychopharmacology. 1993 Feb;8(2):93-5. doi: 10.1038/npp.1993.68. Neuropsychopharmacology. 1993. PMID: 8471131 No abstract available.

2

Dopamine in schizophrenia: a review and reconceptualization.

Davis KL, Kahn RS, Ko G, Davidson M. Davis KL, et al. Among authors: kahn rs. Am J Psychiatry. 1991 Nov;148(11):1474-86. doi: 10.1176/ajp.148.11.1474. Am J Psychiatry. 1991. PMID: 1681750 Review.

3

Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.

Kahn RS, Harvey PD, Davidson M, Keefe RS, Apter S, Neale JM, Mohs RC, Davis KL. Kahn RS, et al. Schizophr Res. 1994 Feb;11(3):217-24. doi: 10.1016/0920-9964(94)90015-9. Schizophr Res. 1994. PMID: 7514887

4

Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.

Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL. Kahn RS, et al. Arch Gen Psychiatry. 1993 Aug;50(8):599-605. doi: 10.1001/archpsyc.1993.01820200009001. Arch Gen Psychiatry. 1993. PMID: 7688208

5

Serotonin, dopamine and their interactions in schizophrenia.

Kahn RS, Davidson M. Kahn RS, et al. Psychopharmacology (Berl). 1993;112(1 Suppl):S1-4. doi: 10.1007/BF02245002. Psychopharmacology (Berl). 1993. PMID: 7831437 Review. No abstract available.

6

Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.

Davidson M, Kahn RS, Stern RG, Hirschowitz J, Apter S, Knott P, Davis KL. Davidson M, et al. Among authors: kahn rs. Psychiatry Res. 1993 Feb;46(2):151-63. doi: 10.1016/0165-1781(93)90017-b. Psychiatry Res. 1993. PMID: 8483974

7

Control of renal factors in plasma homovanillic acid measurements.

Amin F, Stroe AE, Kahn T, Knott PJ, Kahn RS, Davidson M. Amin F, et al. Among authors: kahn rs, kahn t. Neuropsychopharmacology. 1998 Apr;18(4):317-20. doi: 10.1016/S0893-133X(97)00142-5. Neuropsychopharmacology. 1998. PMID: 9509499 Clinical Trial.

8

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.

Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Davidson M, et al. Among authors: kahn rs. Arch Gen Psychiatry. 1991 Oct;48(10):910-3. doi: 10.1001/archpsyc.1991.01810340042005. Arch Gen Psychiatry. 1991. PMID: 1929760

9

Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions.

Kahn RS, Davidson M, Kanof P, McQueeney RT, Singh RR, Davis KL. Kahn RS, et al. Psychopharmacology (Berl). 1991;103(1):95-8. doi: 10.1007/BF02244081. Psychopharmacology (Berl). 1991. PMID: 2006246 Clinical Trial.

10

Assessment of the central dopaminergic index of plasma HVA in schizophrenia.

Amin F, Davidson M, Kahn RS, Schmeidler J, Stern R, Knott PJ, Apter S. Amin F, et al. Among authors: kahn rs. Schizophr Bull. 1995;21(1):53-66. doi: 10.1093/schbul/21.1.53. Schizophr Bull. 1995. PMID: 7770741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,144 results

Search Page

Filters